China Resources Sanjiu Medical & Pharmaceutical Co Ltd Asset Resilience Ratio

Latest as of June 2026: 7.22%

China Resources Sanjiu Medical & Pharmaceutical Co Ltd asset resilience ratio. China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has an Asset Resilience Ratio of 7.22% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 000999 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥4.03 Billion
≈ $590.21 Million USD Cash + Short-term Investments

Total Assets

CN¥55.84 Billion
≈ $8.17 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of China Resources Sanjiu Medical & Pharmaceutical Co Ltd (2002–2025)

Asset resilience ratio of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 2002 to 2025. This chart shows how China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of China Resources Sanjiu Medical & Pharmac for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down China Resources Sanjiu Medical & Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see China Resources Sanjiu Medical & Pharmac balance sheet assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥4.03 Billion 7.22%
Total Liquid Assets CN¥4.03 Billion 7.22%

Asset Resilience Insights

  • Limited Liquidity: China Resources Sanjiu Medical & Pharmaceutical Co Ltd maintains only 7.22% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare China Resources Sanjiu Medical & Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
Drug Manufacturers - Specialty & Generic 0.16%
Sandoz Group AG
SW:SDZ
Drug Manufacturers - Specialty & Generic 7.89%
H Lundbeck A/S
CO:HLUN-B
Drug Manufacturers - Specialty & Generic -0.56%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 5.50%
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
Drug Manufacturers - Specialty & Generic 47.16%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%
Viyash Scientific Limited
NSE:SEQUENT
Drug Manufacturers - Specialty & Generic 0.08%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2002–2025)

China Resources Sanjiu Medical & Pharmaceutical Co Ltd asset resilience ratio by year from 2002 to 2025. The table below shows the annual Asset Resilience Ratio data for China Resources Sanjiu Medical & Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 8.32% CN¥4.89 Billion
≈ $716.13 Million
CN¥58.80 Billion
≈ $8.60 Billion
+4.14pp
2024-12-31 4.18% CN¥1.68 Billion
≈ $245.45 Million
CN¥40.08 Billion
≈ $5.87 Billion
+0.56pp
2023-12-31 3.63% CN¥1.46 Billion
≈ $213.06 Million
CN¥40.15 Billion
≈ $5.87 Billion
-1.34pp
2021-12-31 4.97% CN¥1.22 Billion
≈ $178.35 Million
CN¥24.54 Billion
≈ $3.59 Billion
+4.06pp
2020-12-31 0.90% CN¥200.18 Million
≈ $29.29 Million
CN¥22.15 Billion
≈ $3.24 Billion
-2.05pp
2016-12-31 2.95% CN¥400.00 Million
≈ $58.53 Million
CN¥13.55 Billion
≈ $1.98 Billion
-4.12pp
2015-12-31 7.07% CN¥850.00 Million
≈ $124.38 Million
CN¥12.02 Billion
≈ $1.76 Billion
-3.24pp
2014-12-31 10.31% CN¥1.10 Billion
≈ $160.96 Million
CN¥10.67 Billion
≈ $1.56 Billion
+4.30pp
2013-12-31 6.01% CN¥600.00 Million
≈ $87.80 Million
CN¥9.98 Billion
≈ $1.46 Billion
+5.94pp
2006-12-31 0.08% CN¥5.65 Million
≈ $827.07K
CN¥7.13 Billion
≈ $1.04 Billion
+0.00pp
2005-12-31 0.08% CN¥5.33 Million
≈ $780.39K
CN¥7.04 Billion
≈ $1.03 Billion
+0.00pp
2002-12-31 0.07% CN¥5.02 Million
≈ $734.12K
CN¥6.85 Billion
≈ $1.00 Billion
--
pp = percentage points

About China Resources Sanjiu Medical & Pharmaceutical Co Ltd

SHE:000999 China Drug Manufacturers - Specialty & Generic
Market Cap
$6.25 Billion
CN¥42.72 Billion CNY
Market Cap Rank
#3004 Global
#341 in China
Share Price
CN¥25.67
Change (1 day)
-0.77%
52-Week Range
CN¥22.16 - CN¥30.53
All Time High
CN¥1328.34
About

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, flu, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug prod… Read more